- Home
- BLRX vs YMAT Comparison
BLRX vs YMAT Comparison
Compare BLRX & YMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLRX | YMAT |
|---|---|---|
| Founded | 2003 | 1970 |
| Country | Israel | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6M | 14.4M |
| IPO Year | 2011 | 2025 |
Fundamental Metrics
Financial Performance| Metric | BLRX | YMAT |
|---|---|---|
| Price | $2.98 | $0.56 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $19.00 | N/A |
| AVG Volume (30 Days) | 23.3K | ★ 105.3K |
| Earning Date | 11-24-2025 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $12,735,000.00 | ★ $20,054,081.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.83 |
| Revenue Growth | N/A | ★ 11.79 |
| 52 Week Low | $2.30 | $0.40 |
| 52 Week High | $7.77 | $6.45 |
Technical Indicators
Market Signals| Indicator | BLRX | YMAT |
|---|---|---|
| Relative Strength Index (RSI) | 42.91 | N/A |
| Support Level | $2.82 | N/A |
| Resistance Level | $2.99 | N/A |
| Average True Range (ATR) | 0.18 | 0.00 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 46.66 | 0.00 |
Price Performance
Historical ComparisonAbout BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About YMAT J-Star Holding Co. Ltd. Ordinary Shares
J Star Holding Co Ltd is engaged in the research, development and manufacturing of carbon fiber for a wide variety of products including carbon bicycles, carbon rackets, automotive parts, outdoor sports gears, and healthcare products.